首頁 › 硬皮症 › 紐約州 › New York City
New York City, NY 的 硬皮症 臨床試驗
11 項針對 硬皮症 的研究正在 New York City（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
招募中3 期
- Hospital for Special Surgery, New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center-New York Presbyterian Hospital, New York
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
招募中1 期
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
招募中1 期
- Icahn School of Medicine at Mount Sinai, New York
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
招募中2/3 期
- GSK Investigational Site, New York
- GSK Investigational Site, New York
Platform Clinical Study for Conquering Scleroderma
招募中2 期
- Hospital for Special Surgery, New York
- Columbia University Medical Center, New York
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
招募中2/3 期
- Columbia University Irving Medical Center, New York
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
招募中1/2 期
- Nkarta Investigational Site, New York
A Study of AZD0120 in Autoimmune Diseases
招募中1 期
- Research Site, New York
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
招募中1 期
- Montefiore Medical Center, New York
Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis
招募中2 期
- Hospital for Special Surgery, New York
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
招募中2 期
- aTyr Investigative Site, New York
其他城市的 硬皮症 試驗
- Ann Arbor, MI10 項研究
- Chicago, IL10 項研究
- Houston, TX9 項研究
- Boston, MA7 項研究
- Durham, NC7 項研究
- Los Angeles, CA7 項研究
- New Orleans, LA6 項研究
- Baltimore, MD6 項研究
- Philadelphia, PA6 項研究
- Dallas, TX5 項研究
- Pittsburgh, PA5 項研究
- Plantation, FL4 項研究
New York City 的其他研究
- 乳癌134 項研究
- 非小細胞肺癌120 項研究
- 癌症（所有類型）110 項研究
- 前列腺癌103 項研究
- 轉移性癌症93 項研究
- 大腸直腸癌77 項研究
- 卵巢癌69 項研究
- 肺癌60 項研究
- 胰臟癌60 項研究
- 多發性骨髓瘤60 項研究
- 子宮內膜癌52 項研究
- 心臟衰竭51 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。